English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe federally funded pathway programs strive to increase diversity and equity in the cancer research field, a key strategy to reduce health disparities in the Chicagoland area and across the country.
Tag: Oncology
UTSW Research: Python guts, emergency room visits, and more
Regeneration insights from snake intestines / Understanding why cancer patients visit the ED / How burr holes affect transcranial direct current stimulation
ACS Study Finds Early-Onset Colorectal Cancer Cases Surge Globally
A new study led by American Cancer Society (ACS) researchers shows that early-onset colorectal cancer (CRC) incidence rates are rising in 27 of 50 countries/territories worldwide, 20 of which have either exclusive or faster increases for early-onset disease. In 14 countries, including the United States, rates are increasing in young adults while stabilizing in those 50 years and older. The research is published today in the journal The Lancet Oncology.
ASH: Triplet combination regimens demonstrate high response rates in multiple leukemias
Three clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated significant positive results from novel triplet therapies in the treatment of relapsed or refractory and newly diagnosed leukemias. The results were presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition. More information on all ASH Annual Meeting content from MD Anderson can be found at MDAnderson.org/ASH.
U-M Rogel Cancer Center names 2 new clinical research leaders
The University of Michigan Rogel Cancer Center has named Kyle Cuneo, M.D., its new associate director for clinical research. In addition, a new position of assistant director for clinical research will be filled by John Magenau, M.D.
Unexpected findings in study of T cells considered front-line fighters against advanced melanoma
Yale researchers made an unexpected discovery—turncoat T cells that help a tumor evade other cancer-fighting immune T cells—in a study of patients living with advanced melanoma that was published Nov. 28 in Nature Immunology.
Healthcare to Research: The Many Ways Genetic Counselors Help Patients and Families
Genetic counselors are experts in genetics and how it impacts our health and development. Learn more about who they are, what they do and how they may help you and your family….
International Cancer Organizations Present Collaborative Work During Oncology Event in China
The National Comprehensive Cancer Network (NCCN) is honored to participate in 2024 CCHIO. NCCN has taken numerous strides in recent years to increase the global accessibility and relevance of NCCN Guidelines as a tool for helping people with cancer to live better lives, including multiple collaborations with leading oncology groups in China.
William K. Oh, MD, Joins Yale Cancer Center and Smilow Cancer Hospital
William K. Oh, MD, has been appointed as Medical Director of Smilow Cancer Hospital at Greenwich Hospital, as well as Director of Precision Medicine for Yale Cancer Center and Smilow Cancer Hospital.
ACS Research Finds Lack of Health Insurance Coverage Contributes to Racial and Ethnic Disparities in Advanced-Stage Diagnosis of Multiple Cancers
A new, large study led by American Cancer Society (ACS) researchers found that lack of health insurance coverage accounts for a significant proportion of racial and ethnic disparities in advanced-stage diagnosis of multiple cancers.
NIH Director Monica M. Bertagnolli Honored with NIAF Leonardo da Vinci Award in Health and Science
The National Italian American Foundation (NIAF) presented its Leonardo da Vinci Award in Health and Science to National Institutes of Health (NIH) Director Monica M. Bertagnolli Saturday at the 49th annual NIAF gala in Washington, D.C.
Lymph Node-Like Structures May Trigger the Demise of Cancer Tumors
A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular carcinoma, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center.
Memorial Sloan Kettering Physician-Scientists Elected to the Prestigious National Academy of Medicine
Dr. Deb Schrag, Chair of the Department of Medicine, and Dr. Lorenz Studer, Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists worldwide.
Breast Surgeon Laurie J. Kirstein, MD, FACS, Is New Chair of the ACS Commission on Cancer
Laurie J. Kirstein, MD, FACS, a surgical oncologist from Memorial Sloan Kettering Cancer Center (MSK) who specializes in the treatment of breast cancer, will begin a two-year term as the new chair of the American College of Surgeons (ACS) Commission on Cancer (CoC).
Steven K. Libutti, MD, FACS, Named Inaugural William N. Hait Director at Rutgers Cancer Institute
Today, the Rutgers Board of Governors appointed Steven K. Libutti, MD, FACS, as the inaugural William N. Hait Director of Rutgers Cancer Institute, a position named in honor of the institute’s founding director.
Scientific conference series aims to improve outcomes for diabetes, cancer and cardiovascular disease
The Endocrine Society, a global organization that promotes endocrinology research and clinical practice, and Keystone Symposia, a nonprofit host of conferences and symposia on a range of life science and biomedical topics, will jointly host a series of three conferences to advance endocrine research.
Partners Celebrate Milestone in Development of the Vogel Medical Campus at Tinton Falls
Monmouth Medical Center (MMC), an RWJBarnabas Health facility, raised the final beam at the Specialty and Cancer Care Pavilion at the Vogel Medical Campus on October 8, marking a significant milestone in the system’s commitment to bring care closer to where people live, work and play across Monmouth County.
One-Third of Cancer-Related Crowdfunding Campaigns Share Medical Financial Hardship and Health-Related Social Needs, New Research Shows
In a new, large comprehensive analysis led by the American Cancer Society (ACS), researchers, using a form of Artificial Intelligence (AI), found that more than one-third of fundraising stories on the GoFundMe crowdfunding platform in the United States explicitly shared experiences of medical financial hardships and health-related social needs
Gut Microbiome Health Tech Innovator, Ixcela Launches Virtual Clinic to Ease Cancer Symptoms After Landmark Roper St. Francis Healthcare Pilot
In recognition of Breast Cancer Awareness month, Ixcela, The Internal Fitness™ Company, in collaboration with Roper St. Francis Healthcare, today announced the Ixcela Cancer Support Program.
St. Jude names M. Madan Babu, PhD, senior vice president and chief data scientist
In his new role, Babu will bring new, advanced computing technologies and data science approaches to biomedical research. His team will also facilitate the integration of biological and biomedical data, foster a data science research culture, and build international collaborations.
New ACS Report: Breast Cancer Mortality Continues Three Decade Decline Overall, but Steeper Increases in Incidence for Women <50 & Asian American, Pacific Islanders of all Ages
The American Cancer Society (ACS) today released Breast Cancer Statistics, 2024, the organization’s biennial update on breast cancer occurrence and trends in the United States. The new report finds breast cancer mortality rates overall have dropped by 44% since 1989, averting approximately 517,900 breast cancer deaths. However, not all women have benefited from this progress, notably American Indian and Alaska Native (AIAN) women, whose rates have remained unchanged over the past three decades
Breast cancer experts & story ideas
Sylvester Comprehensive Cancer Center experts attack breast cancer on multiple fronts to advance cures, reduce racial disparities and save lives. New imaging and surgical techniques help.
Paso del Norte Health Foundation Announces $5 Million Grant to Texas Tech Health El Paso to Transform Cancer Care for Our Borderplex Community
The PdNHF has long been a trusted partner of Texas Tech Health El Paso, focused on leading, investing in, and supporting programs that promote health and prevent disease in our Borderplex region. The $5 million grant will be instrumental in elevating comprehensive cancer care by funding the recruitment of top-tier cancer specialists. This ensures the future center will be equipped to deliver expert care from its inception. Dr. Lange called it a foundational grant because it’s a cornerstone of the funding for the future Fox Cancer Center, emphasizing that through collective strength and action – the power of people – we can bring hope to members of our Borderplex community.
American Cancer Society Experts Presenting Key Research at 2024 ASCO Quality Care Symposium
Scientists from the American Cancer Society (ACS) are presenting research studies at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) Quality Care Symposium (QCS) September 27-28 in San Francisco, CA.
New Study Finds Higher County-Level Jail and State-Level Prison Incarceration Rates Associated With Higher County- and State-Level Cancer Mortality Rates
A new nationwide study led by American Cancer Society researchers finds that higher county-level jail and state-level prison incarceration rates in the United States were associated with higher county- and state-level cancer mortality rates, especially for liver and lung cancers. The findings are published today in the Journal of the National Cancer Institute.
New study seeks to develop a new treatment strategy to prevent/delay relapse of myeloid leukemia associated with Down syndrome
A four-year, $1.2 million grant from the National Cancer Institute of the National Institutes of Health to Wayne State University may help researchers find new clues to the interplay between Down syndrome and myeloid leukemia.
SHRO Scientist Named FDA-AACR Cancer Research Fellow
Canio Martinelli, M.D., MSc, GYN-OB resident at the University of Messina and visiting Ph.D. student in Translational Molecular Medicine and Surgery at the Sbarro Health Research Organization (SHRO), Temple University, has been honored with the 2024-2025 FDA-AACR Oncology Educational Fellowship.
Atrium Health Wake Forest Baptist Comprehensive Cancer Center Celebrates 50 Years of National Cancer Institute Designation
Atrium Health Wake Forest Baptist’s Comprehensive Cancer Center is marking 50 years of National Cancer Institute (NCI) designation.
The Battle against glioblastoma: classifying molecular profiles for precision medicine
A transformative study has provided a profound understanding of glioblastoma’s molecular subtypes, revealing the nuances of cellular heterogeneity and the mechanisms behind resistance to treatment. This critical research not only enhances our comprehension of this aggressive cancer but also opens new frontiers for the precision-targeting of therapies, potentially improving patient outcomes significantly.
Generation X and Millennials in U.S. Have Higher Risk of Developing 17 Cancers Compared to Older Generations, New Study Suggests
A new large study led by researchers at the American Cancer Society suggests incidence rates continued to rise in successively younger generations in 17 of the 34 cancer types, including breast, pancreatic, and gastric cancers.
FAU Researcher Receives Grant to Personalize Radiation Therapy for Cancer
While chemotherapy has advanced in personalization, personalized radiation therapy for cancer remains underdeveloped. A new project will use AI, in particular, deep reinforcement learning, to analyze multimodal data, and enhance cancer characterization and treatment to ultimately improve patient outcomes. Using personal health data, genetic information about the tumor, and patient treatment and follow-up data, digital twins will simulate diagnoses and treatment options to help physicians choose the most effective treatments and monitor responses over time.
New Study Finds 40-Percent of Cancer Cases and Almost Half of all Deaths in the U.S. Linked to Modifiable Risk Factors
A new study led by researchers at the American Cancer Society finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States could be attributed to modifiable risk factors, including cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections.
Call for Papers: Theme Issue: Artificial Intelligence in Oncology
JMIR Publications invites submissions to a new theme issue titled “Artificial Intelligence in Oncology” in its premier open access journal JMIR Bioinformatics and Biotechnology indexed in PubMed Central and PubMed, SCOPUS, Sherpa/Romeo, DOAJ and EBSCO/EBSCO Essentials.
Ultrasounds may not find this cancer in Black women
The study looked back at ultrasound data from 1,500 Black women who ended up undergoing hysterectomy at 10 health centers. The study found that having a thinner endometrium measured on transvaginal ultrasound did not mean that there was no cancer risk.
Lack of healthcare screening puts gender diverse people at greater cancer risk
The lack of culturally safe health screening for people who are transgender and gender diverse (TGD) is putting them at greater risk of cancer going undetected, but nurse practitioners could be trained to help close the gap.
Wren Laboratories Unveils Dynamic Executive Leadership Team and 2024 Commercial Strategy Overhaul
Wren Laboratories announced executive leadership for commercial operations and market expansion. Dr. Abdel Halim is appointed CEO and CSO. Troy Tremaine Appointed to CCO, Dr. Eva Szarek Head of Marketing, and Melissa Ferone director of quality. Expansion includes AI-driven mRNA liquid biopsy genomic assays for biopharma and diagnostics.
New Study Finds Most Eligible U.S. Adults not Getting Screened for Lung Cancer
A new study led by American Cancer Society researchers shows less than one-in-five eligible individuals in the United States were up-to-date with recommended lung cancer screening. The screening uptake was much lower in persons without health insurance or usual source of care and in Southern states with the highest lung cancer burden.
Saint Louis University Nursing Professor Honored With Distinguished Researcher Award
Verna Hendricks-Ferguson, Ph.D., the Irene Riddle Endowed Chair and tenure professor at the Trudy Busch Valentine School of Nursing, was honored with the 2024 Distinguished Researcher Award by the Oncology Nursing Society.
ASCO: Proton therapy demonstrates advantages in Phase III head and neck cancer trial
According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy (IMRT) as part of chemoradiation treatment for patients with oropharyngeal (head and neck) cancer.
Phase 1/2 trial of the XPO1 inhibitor selinexor in combination with docetaxel in previously treated, advanced KRAS mutant non-small cell lung cancer (NSCLC)
Background: KRAS mutant NSCLC remains a therapeutic challenge. Although KRAS G12C inhibitors are now approved for cases harboring that specific mutation, their efficacy is modest and the G12C variant accounts for only 40% of KRAS mutations in NSCLC. To date,…
Evaluating the impact of socioeconomic status on patient satisfaction in radiation oncology
Background: Patient satisfaction (PS) is a critical indicator in evaluating healthcare quality. While the impact of socioeconomic status (SES), on healthcare outcomes is well-documented, its specific connection to PS in the context of radiation oncology remains unclear. This study aims to…
Get Ready for ASCO 2024 Annual Meeting
ASCO, the largest event in cancer research, is approaching on May 31st. This year’s meeting promises to be particularly groundbreaking, with new findings and innovations that could revolutionize cancer treatment.
ACS Inaugural Report Shows Mortality for Preventable Cancers Among Native Hawaiian and Other Pacific Islanders in U.S. is 2-3 Times as High as White People
The American Cancer Society today released a first-of-its-kind Cancer Facts & Figures for Asian American, Native Hawaiian, & Other Pacific Islander People, 2024-2026. This report shows that despite limited disaggregated data, there is wide variation in the cancer burden among ethnic groups that make up this fast-growing population.
Unlocking the immune system: cGAS-STING pathway offers new hope for cancer breakthroughs
A groundbreaking study has recognized the cGAS-STING signaling pathway as a formidable ally in the immune system’s battle against cancer. This pivotal discovery may pave the way for innovative immunotherapies capable of amplifying the body’s inherent defenses to detect and eradicate cancer cells, signifying a substantial advance towards more potent cancer treatments.
Annals supplement highlights important new evidence readers ‘may have missed’ in 2023
A new supplement published in Annals of Internal Medicine highlights important new evidence published in 2023 that readers may have missed.
Reimagining Cancer Team Science: Six Hallmarks of Cancer Collaboration
The oncology community has a powerful opportunity to speed the creation of impactful new treatments by adopting a modern playbook for collaboration, according to scientists from Break Through Cancer and other team-oriented cancer organizations working together in a commentary in the journal Cancer Discovery
Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer
Andrew E. Place, MD, PhD, has been named as Vice President, Pediatric Chief Medical Officer (CMO) at Dana-Farber Cancer Institute (within the Department of Pediatric Oncology) and Boston Children’s Hospital (within the Division of Hematology/Oncology) for the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
Aster Insights Announces AACR Schedule of ORIEN Presentations
Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced its schedule of research presentations at the American Association for Cancer Research (AACR) annual meeting in San Diego, California, April 5-10, 2024.
Medical and Psycho-Oncologists Available for Interviews
If you are seeking an expert to discuss chemotherapy and coping with potential side effects following a cancer diagnosis, Dr. Mikkael Sekeres is available. We also have available psycho-oncologists who can discuss the psychosocial aspects of dealing with the shock…
Dr. Nima Sharifi Pens JAMA Commentary on Prostate Cancer Variant His Team Identified
Desai Sethi Urology Institute (DSUI) Scientific Director Nima Sharifi, M.D., authored an invited commentary in JAMA Network Open related to a new Million Veteran Program study on the HSD3B1 genotype, an allele he helped discover more than 10 years ago.